High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study

20237 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov Identifier: NCT02967679; date 2016/12/05.

Good health and well-being

Published in: BMC Neurology

Volume 23, Issue 1, pp. 389-389

Field-Weighted Citation Impact: 1.44